Counting the costs of chemotherapy in a national cancer institute of Canada randomized trial in nonsmall-cell lung cancer

Journal of Clinical Oncology

Volumn 8, Issue 8, 1990, Pages 1301-1309

  Jaakkimainen, Liisa ^a   Goodwin, Pamela J ^a,f,g   Pater, Joseph ^b   Warde, Padraig ^c   Murray, Nevin ^d   Rapp, Edna ^e  

^a UNIVERSITY OF TORONTO   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e TOM BAKER CANCER CENTRE   (Canada)

^f ONTARIO MINISTRY OF HEALTH AND LONG TERM CARE   (Canada)

^g MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; VINDESINE;

ARTICLE; CANCER CHEMOTHERAPY; DRUG COST; ECONOMIC ASPECT; HUMAN; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CANADA; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMPARATIVE STUDY; COST-BENEFIT ANALYSIS; CYCLOPHOSPHAMIDE; DOXORUBICIN; GOVERNMENT AGENCIES; HOSPITALIZATION; HUMAN; LIFE SUPPORT CARE; LUNG NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; VINDESINE;

EID: 0024996201     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1990.8.8.1301     Document Type: Article

References (22)

1. Rapp E, Pater JL, Willan A, et al: Chemotherapy can prolong survival in patients with advanced non-small cell lung cancer - Report of a Canadian multicenter randomized trial. J Clin Oncol 6:633-641, 1988
2. Weinstein MC: Cost-effectiveness analysis for clinical procedures in oncology. Bull Cancer (Paris) 67:491-500, 1980
3. Drummond MF, Stoddart GL, Torrance GW: Methods for the Economic Evaluation of Health Care Programmes. New York, NY, Oxford University Press, 1987
4. Weinstein MC, Stason WB: Foundations of cost-effectiveness analysis for health and medical practices. New Engl J Med 296:716-721, 1977
5. Statistics Canada: Consumer price index: Health and personal care. Ottawa, Canada 14:36, 1989
6. Statistics Canada: Consumer price index: Health and personal care. Ottawa, Canada 10:35, 1985
7. Hull RD, Hirsh J, Sackett DL, et al: Cost-effectiveness of primary and secondary prevention of fatal pulmonary embolism in high-risk surgical patients. Can Med Assoc J 127:990-995, 1982
8. Horngren CT: Cost accounting. A managerial emphasis (ed 5). Englewood Cliffs, NJ, Prentice-Hall, 1982, pp 43-78, 363-402, 438-474, 475-530
9. Goodwin P, Feld R, Evans WK, et al: Cost effectiveness of cancer chemotherapy: An economic evaluation of a randomized trial in small-cell lung cancer. J Clin Oncol 6:1537-1547, 1988
10. Shepard DS, Thompson MS: First principles of cost-effectiveness analysis in health. Pub Health Rep 96:535-543, 1979
11. Atherton L: The cost of radiotherapy treatments on a linear accelerator. Br J Radiol 57:106-107, 1984
12. Ilbery PLT: Cost of health care services in the treatment of cancer. Aust Fam Phys 7:1062-1074, 1978
13. Greene DR: The cost of radiotherapy treatments on a linear accelerator. Br J Rad 56:189-191, 1983
14. Wodinsky HB, Jenkin RDT: The cost of radiation treatment at an Ontario regional cancer centre. Can Med Assoc J 137:906-909, 1987
15. Friedlander ML, Tattersall MHN: Counting the costs of cancer therapy. Eur J Cancer Clin Oncol 18:1237-1241, 1982
16. Calman JC, McVie JG, Soukop M, et al: Cost of outpatient chemotherapy. Br Med J 1:493-494, 1978
17. Goldman L, Sia B, Cook EF, et al: Cost and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction. N Engl J Med 319:152-157, 1988
18. Love RR, Fryback DC, Kimbrough SR: A cost-effectiveness analysis of screening for carcinoma of the prostate by digital examination. Med Decis Making 5:263-278, 1985
19. Pliskin JS, Stason WB, Weinstein MC, et al: Coronary artery bypass graft surgery: Clinical decision making and cost-effectiveness analysis. Med Decis Making 1:10-28, 1981
20. Roberts SD, Maxwell DR, Gross TL: Cost-effective care of end-stage renal disease: A billion dollar question. Ann Intern Med 93:499-500, 1980
21. Rosenshein MS, Farewell VT, Price TH, et al: The cost-effectiveness of therapeutic and prophylactic leukocyte transfusion. N Engl J Med 302:1508-1062, 1980
22. Weinstein MC: Estrogen use in postmenopausal women - Costs, risks, and benefits. N Engl J Med 303:308-316, 1980